Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.31 USD | -2.05% | -11.13% | -21.64% |
Mar. 27 | North American Morning Briefing : Stocks Edge -2- | DJ |
Mar. 25 | Marker Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 9.01M | Sales 2023 | 3.31M | Capitalization | 48.89M |
---|---|---|---|---|---|
Net income 2022 | -29M | Net income 2023 | -8M | EV / Sales 2022 | 2.06 x |
Net cash position 2022 | 4.17M | Net cash position 2023 | 15.11M | EV / Sales 2023 | 10.2 x |
P/E ratio 2022 |
-0.74
x | P/E ratio 2023 |
-5.88
x | Employees | 8 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.83% |
Latest transcript on Marker Therapeutics, Inc.
1 day | -2.05% | ||
1 week | -11.13% | ||
Current month | +0.23% | ||
1 month | -2.71% | ||
3 months | -0.46% | ||
6 months | +24.93% | ||
Current year | -21.64% |
Managers | Title | Age | Since |
---|---|---|---|
Juan F. Vera
CEO | Chief Executive Officer | 44 | 18-10-16 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 18-10-16 | |
Steven Elms
BRD | Director/Board Member | 60 | 19-08-05 |
Katharine Knobil
BRD | Director/Board Member | 60 | 21-12-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 4.31 | -2.05% | 10,625 |
24-04-16 | 4.4 | -0.90% | 15,037 |
24-04-15 | 4.44 | +3.02% | 31,885 |
24-04-12 | 4.31 | -6.30% | 20,306 |
24-04-11 | 4.6 | -5.15% | 19,131 |
Delayed Quote Nasdaq, April 17, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-21.64% | 39.17M | |
-1.78% | 41.71B | |
+47.70% | 41.56B | |
+4.01% | 39.74B | |
-15.14% | 25.61B | |
+3.16% | 24.26B | |
-24.08% | 18.55B | |
-2.67% | 11.93B | |
+24.76% | 11.93B | |
+7.01% | 10.91B |
- Stock Market
- Equities
- MRKR Stock